See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
World Cup
Boxing
Elon Musk
WWE
Social Media
Donald Trump
Baseball
Natural Disasters
Eid
Cristiano Ronaldo
Artificial Intelligence
Soccer
Published • loading... • Updated

Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post-Progression

Summary by Pharmacy Times
Granted accelerated approval by the FDA in 2024, tarlatamab continues to demonstrate efficacy and safety in patients with small cell lung cancer, with results showing improved overall survival and progression-free survival in patients who had progressed or previously received chemotherapy.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
cancernetwork.comcancernetwork.com

Socazolimab Exhibits Overall Survival Benefit Vs Placebo in ES-SCLC

The addition of socazolimab to carboplatin plus etoposide was well tolerated compared with placebo in patients with extensive-stage small cell lung cancer.

Read Full Article
Pharmacy TimesPharmacy Times

Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post-Progression

Granted accelerated approval by the FDA in 2024, tarlatamab continues to demonstrate efficacy and safety in patients with small cell lung cancer, with results showing improved overall survival and progression-free survival in patients who had progressed or previously received chemotherapy.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pharmacy Times broke the news in on Friday, June 6, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States

United States

News
For You
SearchBlindspotLocal